ArticleJournal of molecular medicine (Berlin, Germany)2014

A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (MMP1) in endometrial cancer.

Chiao-Yun Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.